|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.98 SAR | -1.14% |
|
+1.23% | +1.23% |
| 12-22 | Middle East Healthcare appoints Nezar Mohammed Sultan Bahabri as CEO | RE |
| 12-22 | Saudi German Health Names Chief Medical Officer as New CEO | MT |
| Capitalization | 3.07B 819M 703M 654M 609M 1.14B 73.91B 1.22B 7.52B 2.96B 35.36B 3.01B 130B | P/E ratio 2025 * |
9.78x | P/E ratio 2026 * | 11x |
|---|---|---|---|---|---|
| Enterprise value | 5.36B 1.43B 1.23B 1.14B 1.06B 1.98B 129B 2.14B 13.13B 5.16B 61.71B 5.25B 226B | EV / Sales 2025 * |
1.73x | EV / Sales 2026 * | 1.48x |
| Free-Float |
45.31% | Yield 2025 * |
1.5% | Yield 2026 * | 3.28% |
| 1 day | -1.08% | ||
| 1 week | +1.35% | ||
| Current month | +1.35% | ||
| 1 month | -6.09% | ||
| 3 months | -43.10% | ||
| 6 months | -42.66% | ||
| Current year | +1.35% |
| 1 week | 32.48 | 34.22 | |
| 1 month | 31.46 | 36.02 | |
| Current year | 31.46 | 34.22 | |
| 1 year | 31.46 | 84.8 | |
| 3 years | 26.1 | 134.4 | |
| 5 years | 25 | 134.4 | |
| 10 years | 23.88 | 134.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 15/07/2019 | |
| President | 47 | 17/09/2017 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sobhi Batterjee
CHM | Chairman | - | 17/09/2014 |
| Director/Board Member | 47 | 17/09/2014 | |
| Director/Board Member | 41 | 17/09/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.08% | +1.35% | -55.70% | +24.53% | 819M | ||
| -0.12% | -1.05% | +19.01% | +41.54% | 18.43B | ||
| -1.01% | +4.09% | -7.50% | -54.83% | 15.62B | ||
| -0.53% | -2.35% | +8.43% | +67.74% | 11.58B | ||
| -0.16% | -0.45% | +33.02% | +80.23% | 10.21B | ||
| -0.08% | -5.78% | +7.69% | +64.24% | 10.08B | ||
| +2.27% | -7.69% | -23.08% | -40.50% | 9.1B | ||
| 0.00% | -3.50% | -31.30% | - | 7.5B | ||
| +0.21% | -3.28% | +37.13% | +216.34% | 7.61B | ||
| +0.22% | +3.25% | +6.38% | -45.11% | 5.65B | ||
| Average | -0.02% | -1.49% | -0.59% | +39.35% | 9.66B | |
| Weighted average by Cap. | -0.02% | -1.66% | +5.94% | +35.95% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.1B 827M 710M 661M 615M 1.15B 74.69B 1.24B 7.6B 2.99B 35.73B 3.04B 131B | 3.51B 935M 802M 747M 695M 1.3B 84.39B 1.4B 8.59B 3.38B 40.37B 3.43B 148B |
| Net income | 314M 83.86M 71.96M 67M 62.35M 116M 7.57B 125M 770M 303M 3.62B 308M 13.27B | 281M 74.92M 64.29M 59.86M 55.7M 104M 6.76B 112M 688M 271M 3.24B 275M 11.86B |
| Net Debt | 2.29B 610M 524M 488M 454M 847M 55.1B 913M 5.61B 2.21B 26.36B 2.24B 96.58B | 2.11B 563M 483M 450M 418M 781M 50.79B 841M 5.17B 2.03B 24.3B 2.07B 89.03B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 32.98 ﷼ | -1.14% | 290,995 |
| 14/01/26 | 33.36 ﷼ | -1.71% | 1,085,344 |
| 13/01/26 | 33.94 ﷼ | -0.06% | 1,126,392 |
| 12/01/26 | 33.96 ﷼ | +1.80% | 1,081,058 |
| 11/01/26 | 33.36 ﷼ | +2.46% | 1,385,385 |
Delayed Quote Saudi Arabian S.E., January 15, 2026 at 11:34 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4009 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















